These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 14016230
21. Treatment of leukemia with triethylene thiophosphoramide (thio-TEPA); preliminary results in experimental and clinical leukemia. SHAY H, ZARAFONETIS C, SMITH N, WOLDOW I, SUN DC. AMA Arch Intern Med; 1953 Nov; 92(5):628-45. PubMed ID: 13091480 [No Abstract] [Full Text] [Related]
22. RECURRENT PTERYGIUM: USE OF TOPICAL TRIETHYLENE THIOPHOSPHORAMIDE. WESSON TW, PETTIS JL. J Miss State Med Assoc; 1965 Feb; 6(2):46-9. PubMed ID: 14256280 [No Abstract] [Full Text] [Related]
23. Phase I/pharmacokinetic reevaluation of thioTEPA. O'Dwyer PJ, LaCreta F, Engstrom PF, Peter R, Tartaglia L, Cole D, Litwin S, DeVito J, Poplack D, DeLap RJ. Cancer Res; 1991 Jun 15; 51(12):3171-6. PubMed ID: 1710167 [Abstract] [Full Text] [Related]
31. [ON SOME HEMATOMEDULLARY CHANGES DURING ANTIBLASTIC THERAPY, WITH SPECIAL REFERENCE TO THIO-TEPA. PRELIMINARY NOTE]. BONERA E, CAPRETTI G. Minerva Radiol Fisioter Radiobiol; 1964 Jan 15; 16():353-5. PubMed ID: 14187607 [No Abstract] [Full Text] [Related]
32. Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients. Hagen B, Neverdal G, Walstad RA, Nilsen OG. Cancer Chemother Pharmacol; 1990 Jan 15; 25(4):257-62. PubMed ID: 1688514 [Abstract] [Full Text] [Related]
33. Thio-TEPA and methotrexate chemotherapy of advanced ovarian carcinoma. Greenspan EM. J Mt Sinai Hosp N Y; 1968 Jan 15; 35(1):52-67. PubMed ID: 4966488 [No Abstract] [Full Text] [Related]
34. [The chemotherapy of malignant tumors of the ovary with thio-TEPA]. WOLFF JP. Pathol Biol; 1960 Dec 15; 8():2301-5. PubMed ID: 13786350 [No Abstract] [Full Text] [Related]
35. [THIO-TEPA THERAPY OF PATIENTS WITH FAR ADVANCED MALIGNANT TUMORS OF THE OVARY]. SIGALOV AB, SOROKA PG. Vopr Onkol; 1963 Dec 15; 9():98-102. PubMed ID: 14149575 [No Abstract] [Full Text] [Related]
36. [DECREASE IN THE ORGANIC RESISTANCE EXERCISED BY TRIETHYLENE THIOPHOSPHORAMIDE IN EXPERIMENTAL INFECTION IN RATS]. SOERENSEN B, ZEZZANETO L, CORREA HC. Rev Bras Cir; 1963 Nov 15; 46():360-1. PubMed ID: 14119056 [No Abstract] [Full Text] [Related]
37. Clinical remission of adenocarcinoma of the ovary induced by triethylene thiophosphoramide. Report of a case. SENECOFF SD, MELLEN HS. Bull Sinai Hosp Detroit; 1962 Nov 15; 10():98-100. PubMed ID: 13987964 [No Abstract] [Full Text] [Related]
38. [Toxic reactions during treatment of the ovarian cancer with ThioTEPA]. Shuvaeva NI, Emel'ianova LS. Akush Ginekol (Mosk); 1974 Oct 15; (10):18-20. PubMed ID: 4216276 [No Abstract] [Full Text] [Related]
39. FURTHER COMPARATIVE TRIAL OF TRIETHYLENE THIOPHOSPHORAMIDE AND MECHLORETHAMINE IN PATIENTS WITH MELANOMA AND HODGKIN'S DISEASE. BRINDLEY CO, SALVIN LG, POTEE KG, LIPOWSKA B, SHNIDER BI, REGELSON W, COLSKY J. J Chronic Dis; 1964 Jan 15; 17():19-30. PubMed ID: 14107166 [No Abstract] [Full Text] [Related]
40. ADJUVANT CHEMOTHERAPY. THIO-TEPA WITH RADICAL MASTECTOMY IN THE TREATMENT OF BREAST CANCER. NOER RJ. Am J Surg; 1963 Sep 15; 106():405-12. PubMed ID: 14062942 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]